(Q84118310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

Barbara Malawska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Kinga Sałat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Katarzyna Kulig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

Robert Sałat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

published in

Pharmacological Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

102-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

GABA and glycine as neurotransmitters: a brief history

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Effect of caffeine on the anticonvulsant effects of oxcarbazepine, lamotrigine and tiagabine in a mouse model of generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

A novel selective gamma-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Unravelling the brain targets of gamma-hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Mechanisms of action of antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The new generation of GABA enhancers. Potential in the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Inhibition of gamma-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) re

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Neurotransmitter transporters and their impact on the development of psychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA puts a stop to pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The role of structure activity relationship studies in the search for new GABA uptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Synergistic interaction of gabapentin with tiagabine in the hot-plate test in mice: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA and neuroactive steroid interactions in glia: new roles for old players?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Investigation into new anticonvulsant derivatives of alpha-substituted N-benzylamides of gamma-hydroxy- and gamma-acetoxybutyric acid. Part 5: search for new anticonvulsant compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Molecular targets for antiepileptic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

An introduction to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Molecular targets versus models for new antiepileptic drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA transporters as targets for new drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA transporters and GABA-transaminase as drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA transporters as drug targets for modulation of GABAergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970736-3

7 January 2021

10.1016/S1734-1140(12)70736-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580526%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference